Literature DB >> 15121513

Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals.

Wolfgang Körner1, Anne Marie Vinggaard, Béatrice Térouanne, Risheng Ma, Carise Wieloch, Margret Schlumpf, Charles Sultan, Ana M Soto.   

Abstract

We evaluated and compared four in vitro assays to detect androgen agonists and antagonists in an international interlaboratory study. Laboratory 1 used a cell proliferation assay (assay 1) with human mammary carcinoma cells stably transfected with human androgen receptor. The other laboratories used reporter gene assays, two based on stably transfected human prostate carcinoma cells (assay 2) or human mammary carcinoma cells (assay 4), and the third based on transient transfection of Chinese hamster ovary cells (assay 3). Four laboratories received four coded compounds and two controls: two steroidal androgens, two antiandrogens, an androgenic control, 5alpha-dihydrotestosterone (DHT), and an antiandrogenic control, bicalutamide (ICI 176,334). All laboratories correctly detected the androgenic activity of 4-androsten-3,17-dione and 17alpha-methyltestosterone. For both compounds, the calculated androgenic potencies relative to the positive control (RAPs) remained within one order of magnitude. However, laboratory 3 calculated a 50-fold higher RAP for 4-androsten-3,17-dione. All assays detected and quantified the antiandrogenic effect of vinclozolin [median inhibitory concentration (IC50) values ranging from 1.1 times symbol 10(-7) M to 4.7 times symbol 10(-7) M]. In assays 2 and 3, vinclozolin showed partial androgenic activity at the highest concentrations tested. For vinclozolin, calculated antiandrogenic potencies relative to bicalutamide (RAAPs) differed no more than a factor of 10, and IC50 values matched those of bicalutamide. Similarly, we found antiandrogenic activity for tris-(4-chlorophenyl)methanol. RAAP values were between 0.086 and 0.37. Three assays showed cytotoxicity for this compound at or above 1 times symbol 10(-5) M. In summary, all assays proved sensitive screening tools to detect and quantify androgen receptor-mediated androgenic and antiandrogenic effects of these chemicals accurately, with coefficients of variation between 8 and 90%.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121513      PMCID: PMC1241964          DOI: 10.1289/ehp.112-1241964

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  36 in total

1.  Expression of different 17beta-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells.

Authors:  L A Castagnetta; G Carruba; A Traina; O M Granata; M Markus; M Pavone-Macaluso; C H Blomquist; J Adamski
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

2.  Molecular basis of agonism and antagonism in the oestrogen receptor.

Authors:  A M Brzozowski; A C Pike; Z Dauter; R E Hubbard; T Bonn; O Engström; L Ohman; G L Greene; J A Gustafsson; M Carlquist
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

3.  Feminization of male carp.

Authors:  S Gimeno; A Gerritsen; T Bowmer; H Komen
Journal:  Nature       Date:  1996-11-21       Impact factor: 49.962

4.  The inhibitory effect of zinc on cadmium-induced cell apoptosis and reactive oxygen species (ROS) production in cell cultures.

Authors:  A Szuster-Ciesielska; A Stachura; M Słotwińska; T Kamińska; R Sniezko; R Paduch; D Abramczyk; J Filar; M Kandefer-Szerszeń
Journal:  Toxicology       Date:  2000-04-14       Impact factor: 4.221

5.  A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects.

Authors:  B Térouanne; B Tahiri; V Georget; C Belon; N Poujol; C Avances; F Orio; P Balaguer; C Sultan
Journal:  Mol Cell Endocrinol       Date:  2000-02-25       Impact factor: 4.102

6.  Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.

Authors:  J Szelei; J Jimenez; A M Soto; M F Luizzi; C Sonnenschein
Journal:  Endocrinology       Date:  1997-04       Impact factor: 4.736

7.  Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide.

Authors:  C Wong; W R Kelce; M Sar; E M Wilson
Journal:  J Biol Chem       Date:  1995-08-25       Impact factor: 5.157

8.  Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays.

Authors:  D M Klotz; B S Beckman; S M Hill; J A McLachlan; M R Walters; S F Arnold
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

9.  Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol.

Authors:  S C Nagel; F S vom Saal; K A Thayer; M G Dhar; M Boechler; W V Welshons
Journal:  Environ Health Perspect       Date:  1997-01       Impact factor: 9.031

10.  The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants.

Authors:  A M Soto; C Sonnenschein; K L Chung; M F Fernandez; N Olea; F O Serrano
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

View more
  8 in total

1.  Androgenic/antiandrogenic activities of PAEs determined by a novel AR-mediated reporter gene assay based on LLC-MK2 cells.

Authors:  Xiaoju Ma; Jing Yang; Hong Jia; Xiaohua Li; Dawei Wang; Hongxia Fu; Jie Yuan; Yun Li; Guangmei Zheng; Xiaoming Huang
Journal:  Toxicol Res (Camb)       Date:  2019-03-21       Impact factor: 3.524

2.  Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis.

Authors:  Si Wang; Jeroen C W Rijk; Harrie T Besselink; René Houtman; Ad A C M Peijnenburg; Abraham Brouwer; Ivonne M C M Rietjens; Toine F H Bovee
Journal:  Toxicol Sci       Date:  2014-06-13       Impact factor: 4.849

3.  Salbutamol exhibits androgenic activity in vitro.

Authors:  André O von Bueren; Risheng Ma; Margret Schlumpf; Walter Lichtensteiger
Journal:  Br J Sports Med       Date:  2007-05-17       Impact factor: 13.800

4.  Triclocarban enhances testosterone action: a new type of endocrine disruptor?

Authors:  Jiangang Chen; Ki Chang Ahn; Nancy A Gee; Mohamed I Ahmed; Antoni J Duleba; Ling Zhao; Shirley J Gee; Bruce D Hammock; Bill L Lasley
Journal:  Endocrinology       Date:  2007-11-29       Impact factor: 4.736

Review 5.  AOP key event relationship report: Linking androgen receptor antagonism with nipple retention.

Authors:  Emilie Bak Pedersen; Sofie Christiansen; Terje Svingen
Journal:  Curr Res Toxicol       Date:  2022-08-30

6.  Competitive androgen receptor antagonism as a factor determining the predictability of cumulative antiandrogenic effects of widely used pesticides.

Authors:  Frances Orton; Erika Rosivatz; Martin Scholze; Andreas Kortenkamp
Journal:  Environ Health Perspect       Date:  2012-09-10       Impact factor: 9.031

7.  Xenoandrogenic activity in serum differs across European and Inuit populations.

Authors:  Tanja Krüger; Philip S Hjelmborg; Bo A G Jönsson; Lars Hagmar; Aleksander Giwercman; Gian-Carlo Manicardi; Davide Bizzaro; Marcello Spanò; Anna Rignell-Hydbom; Henning S Pedersen; Gunnar Toft; Jens Peter Bonde; Eva C Bonefeld-Jørgensen
Journal:  Environ Health Perspect       Date:  2007-12       Impact factor: 9.031

8.  Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects.

Authors:  Adam T Szafran; Maria Szwarc; Marco Marcelli; Michael A Mancini
Journal:  PLoS One       Date:  2008-11-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.